Apyx Medical Corporation Common Stock

APYXNASDAQUSD
4.47 USD
0.18 (4.20%)AT CLOSE (11:59 AM EDT)
4.49
0.02 (0.40%)
POST MARKET (AS OF 05:21 PM EDT)
Post Market
AS OF 05:21 PM EDT
4.49
0.02 (0.40%)
🔴Market: CLOSED
Open?$4.29
High?$4.69
Low?$4.24
Prev. Close?$4.29
Volume?319.0K
Avg. Volume?216.4K
VWAP?$4.50
Rel. Volume?1.47x
Bid / Ask
Bid?$4.33 × 200
Ask?$4.65 × 200
Spread?$0.32
Midpoint?$4.49
Valuation & Ratios
Market Cap?187.2M
Shares Out?41.9M
Float?32.3M
Float %?77.1%
P/E Ratio?N/A
P/B Ratio?14.59
EPS?-$0.22
Dividend?0.00%
Ex-Dividend?N/A

Apyx Medical Corporation Common Stock (APYX) trades at $4.47 per share. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. Notable factors include a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics place APYX at a fair price relative to peers.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.
Employees
205
Market Cap
179.6M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
1994-04-06
Address
5115 ULMERTON ROAD
CLEARWATER, FL 33760
Phone: (727) 384-2323
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+3/3)
Medium-Term (Wave)? Bullish(+3/3)
Short-Term (Ripple)? Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
27
Momentum?
98
Short Sent.?
80
Piotroski F-Score?5/9Mixed
Altman Z-Score?1.75Distress
Confidence?50%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.52%Low
Short Interest?167.4K
Days to Cover?1.0
Free Float32.3M
Avg Daily Volume351.0K
Settlement Date2026-05-15
Financial Health
Current Ratio?5.80Strong
Quick Ratio?4.79Strong
Cash Ratio?3.30Strong
Debt/Equity?2.74High
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A
P/B?
Peers
100
S&P
12
14.59HIGH
P/S?
Peers
100
S&P
46
3.35FAIR
P/FCF?
N/A
EV/EBITDA?
S&P
97
-53.8CHEAP
EV/Sales?
Peers
100
S&P
55
3.42FAIR
Returns & Efficiency
ROE?
S&P
3
-71.5%WEAK
ROA?
S&P
3
-14.5%WEAK
Cash Flow & Enterprise
FCF?$-8990000
Enterprise Value?$191.2M
Fundamentals ratios updated end of day